相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Integrative Genomic Analyses Reveal an Androgen-Driven Somatic Alteration Landscape in Early-Onset Prostate Cancer
Joachim Weischenfeldt et al.
CANCER CELL (2013)
Marked heterogeneity of ERG expression in large primary prostate cancers
Sarah Minner et al.
MODERN PATHOLOGY (2013)
Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer
Antje Krohn et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Novel, gross chromosomal alterations involving PTEN cooperate with allelic loss in prostate cancer
Alison H. M. Reid et al.
MODERN PATHOLOGY (2012)
PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer
Tarek A. Bismar et al.
BJU INTERNATIONAL (2011)
ERG Status Is Unrelated to PSA Recurrence in Radically Operated Prostate Cancer in the Absence of Antihormonal Therapy
Sarah Minner et al.
CLINICAL CANCER RESEARCH (2011)
The genomic complexity of primary human prostate cancer
Michael F. Berger et al.
NATURE (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Distinct Genomic Aberrations Associated with ERG Rearranged Prostate Cancer
Francesca Demichelis et al.
GENES CHROMOSOMES & CANCER (2009)
PTEN genomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer
Kanishka Sircar et al.
JOURNAL OF PATHOLOGY (2009)
Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression
Bo Han et al.
MODERN PATHOLOGY (2009)
Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis
Jennifer C. King et al.
NATURE GENETICS (2009)
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
Brett S. Carver et al.
NATURE GENETICS (2009)
Is PTEN loss associated with clinical outcome measures in human prostate cancer?
P. McCall et al.
BRITISH JOURNAL OF CANCER (2008)
Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome
Maisa Yoshimoto et al.
MODERN PATHOLOGY (2008)
Killin is a p53-regulated nuclear inhibitor of DNA synthesis
Yong-jig Cho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome
M. Yoshimoto et al.
BRITISH JOURNAL OF CANCER (2007)
The PTEN gene in locally progressive prostate cancer is preferentially inactivated by bi-allelic gene deletion
PCMS Verhagen et al.
JOURNAL OF PATHOLOGY (2006)
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
ZB Chen et al.
NATURE (2005)
Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens
AM Wise et al.
UROLOGY (2002)
分享论文
